Register entry
Terumo Pharmaceutical Services GmbH
Data as of · How to read this entry
- Registered sites
- 4
- Active NDC listings
- 12
- Live patents
- 0
- Countries
- 2
- Base
- Japan
Authorisation
Registered operations
Analytical testing3Labelling1Finished drug manufacture4Packaging1sterilize1
Sites
Registered establishments
4| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Terumo Pharmaceutical Services GmbH | Chempark Leverkusen, Building D201, Gate 133, Leverkusen, North Rhine-Westphalia (NRW) 51368, Germany (DEU) | Analytical testing, Finished drug manufacture | 3020028035316586834 |
| FUGAKU EXPRESS CO., LTD.Registrant: TERUMO CORPORATION | 570-7, NARUSHIMA, CHUO, YAMANASHI 409-3815, Japan (JPN) | Finished drug manufacture | 3027446061716832006 |
| Terumo Corporation | 818, Misonodaira, Fujinomiya-City, Shizuoka 418-0004, Japan (JPN) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3002808337695214015 |
| TERUMO CORPORATION | 1727-1,TSUIJIARAI,SHOWACHO, NAKAKOMA-GUN, YAMANASHI 409-3853, Japan (JPN) | Analytical testing, Finished drug manufacture | 3003752255706300449 |
Catalogue
Drug listings by form and route
1212 active NDC listings: 7 human prescription drug, 5 drug for further processing. By marketing category: NDA 7, DRUG FOR FURTHER PROCESSING 5.
| Dosage form | NDCs |
|---|---|
| injection, solution | 5 |
| kit | 4 |
| solution | 3 |
| Route | NDCs |
|---|---|
| intravenous | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| terumo corporation | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ADALIMUMAB | injection, solution | 53877-801DRUG FOR FURTHER PROCESSING |
| - | ADALIMUMAB | injection, solution | 53877-802DRUG FOR FURTHER PROCESSING |
| - | ADALIMUMAB | injection, solution | 53877-803DRUG FOR FURTHER PROCESSING |
| IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative | Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative | kit, intravenous | 53877-006NDA |
| IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative for collection of 500mL of Blood | Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell Preservative | kit | 53877-105NDA |
| - | Lecanemab | injection, solution | 53877-902DRUG FOR FURTHER PROCESSING |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine | solution, intravenous | 53877-109NDA |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine | solution, intravenous | 53877-108NDA |
| TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative Solution for Collection of 500mL of Blood | Dextrose Monohydrate, Trisodium Citrate Dihydrate, Anhydrous Citric Acid, Sodium Phosphate, Monobasic, Unspecified Form, Anhydrous Dextrose, Sodium Chloride, Mannitol, and Adenine | kit | 53877-103NDA |
| TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | dextrose monohydrate, trisodium citrate dihydrate, anhydrous citric acid, sodium phosphate, monobasic, unspecified form, sodium chloride, mannitol, and adenine | kit, intravenous | 53877-101NDA |
| - | lecanemab | injection, solution | 53877-901DRUG FOR FURTHER PROCESSING |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine | solution, intravenous | 53877-110NDA |
Neighbours
Registered in the same town
4- Bayer Healthcare Manufacturing SrlLeverkusen, DEU
- Currenta GmbH & Co. OHGLeverkusen, DEU
- Biofrontera Bioscience GmbHLeverkusen, DEU
- Dynamit Nobel GmbH Explosivstoff- und SystemtechnikLeverkusen, DEU
Compare
Comparable companies in Japan
- Shionogi Pharma Co., Ltd.4 sites · 17 NDC
- Chugai Pharmaceutical Co., Ltd.3 sites · 13 NDC
- Daiichi Sankyo Europe GmbH3 sites · 11 NDC
- Sumitomo Chemical Company, Limited3 sites · 8 NDC
- Meiji Seika Pharma Co., Ltd.3 sites · 1 NDC
- Otsuka America Pharmaceutical, Inc.6 sites · 62 NDC
- Sumitomo Pharma Co., Ltd.2 sites · 24 NDC
- Hisamitsu Pharmaceutical Co., Inc.2 sites · 16 NDC
- Bushu Pharmaceuticals, Ltd.2 sites · 11 NDC
- ASO Pharmaceutical Co. Ltd.2 sites · 10 NDC
Enquiry
Common questions
- Is Terumo Pharmaceutical Services GmbH FDA approved?
- Terumo Pharmaceutical Services GmbH holds 4 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Terumo Pharmaceutical Services GmbH's drugs manufactured?
- At registered sites in Germany, Japan. The FDA register lists Leverkusen; CHUO; Fujinomiya-City; NAKAKOMA-GUN. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, sterilize.
- What drugs does Terumo Pharmaceutical Services GmbH make?
- 12 products are listed under Terumo Pharmaceutical Services GmbH in the openFDA NDC Directory, most often as injection, solution; kit; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.